• The U.S. and EU reach a preliminary trade deal, introducing 15% tariffs on most EU exports to the U.S., avoiding a full-blown trade war.
  • Germany and Ireland face the heaviest impact due to their reliance on car and pharmaceutical exports, while France and Spain see minimal disruption.
  • The deal could cut EU GDP by 0.2% over three years, with Germany's already-struggling economy at particular risk.

A Fragile Compromise

The United States and European Union have struck a preliminary trade agreement that sidesteps an all-out tariff war but imposes a 15% levy on most EU exports to the U.S. The deal, announced after tense negotiations between President Trump and European Commission President Ursula von der Leyen, is not yet final, with critical details like sectoral exemptions still under discussion.

Germany and Ireland are expected to bear the brunt of the new tariffs, given their heavy dependence on U.S.-bound auto and pharmaceutical shipments. Germany’s automotive sector, already grappling with existing 25% tariffs, now faces additional pressure. Meanwhile, France and Spain—with less exposure in the targeted categories—are likely to emerge relatively unscathed.

Economic Fallout

Analysts at Capital Economics estimate the tariffs could shave 0.2% off EU GDP over the next three years, exacerbating growth concerns in Germany, where economic stagnation looms. In exchange for tariff concessions, the EU has agreed to boost purchases of U.S. liquefied natural gas (LNG) and military equipment, alongside increased investment in American markets.

“This is a short-term fix that avoids catastrophe but doesn’t resolve underlying tensions,” said one Brussels-based trade expert, speaking on condition of anonymity. “Businesses on both sides will face higher costs, and consumers may see price hikes.”

What’s Next?

The agreement mirrors recent U.S. deals with Japan and the UK, blending tariffs with side agreements on investment and sectoral purchases. However, with carve-outs for industries like aerospace and spirits still unresolved, businesses remain in limbo. Market watchers warn of prolonged volatility in auto and pharma stocks, while governments in affected nations mull subsidies for vulnerable sectors.

Correction: An earlier version misstated the potential GDP impact as 0.3%. The correct figure is 0.2%.